Biotech Germany: The Qiagen Story with Prof. Riesner (Part 2)

Join us as Professor Detlev Riesner, co-founder of Qiagen, reveals the secrets behind building a global biotech powerhouse. Launching Qiagen in 1980s Germany, a time when venture capital was scarce and the path from research to market success was uncharted, Professor Riesner didn’t just imagine it—he lived it. 👉 Vanta automates security and compliance, save 1.000 US$ with us by signing up with this link: vanta.com/startupradio In this exclusive interview, you’ll learn: The founding story of Qiagen and its groundbreaking achievement as the first German company to list on Nasdaq! 🚀 Professor Riesner’s firsthand account of overcoming early-stage biotech challenges and securing funding. Key strategies for bridging the gap between academic research and building a thriving business. Insights into the evolution of Germany's biotech ecosystem and its impact on innovation. Professor Riesner’s advice for biotech entrepreneurs, tech founders, and investors. A must-listen for those interested in: Biotech entrepreneurship and startups Biotech funding and investment University spin-offs and technology transfer Building and scaling successful biotech companies The history and future of the German biotech industry Ready to be inspired? Professor Riesner’s profound insight: "It has to be in the mind of the administration of these people to help and not to ask money from people who don't have the money." This insight encapsulates the challenges and potential of academic entrepreneurship. Episode Highlights: The influence of a Nobel laureate on Professor Riesner’s academic journey. Transitioning from academia to building a biotech company. Overcoming funding challenges in biotech’s early days. Qiagen’s historic Nasdaq listing. The evolution of Germany's biotech ecosystem. Professor Riesner’s advice for aspiring biotech entrepreneurs. Learn more about Professor Detlev Riesner: Wikipedia: Detlev Riesner QIAGEN: Prof. Dr. Detlev Riesner in Hall of Fame Connect with Startuprad.io: Work with us – Reach out: [email protected] Subscribe to our podcast Give us feedback Follow our Editor-in-Chief / Founder on LinkedIn #BiotechEntrepreneurship #BiotechStartups #BiotechInnovation #BiotechFunding #UniversitySpinOffs #Qiagen #GermanBiotech #DACHStartups #AcademicEntrepreneurship #BiotechIndustry #Entrepreneurship #StartupSuccess #BiotechGermany #BiotechHistory #BiotechLeadership #VentureCapital #Nasdaq #Startupradio Share this episode with your network!

There are no comments yet.

Please log in to write the first comment.